Valensa International LLC - Strategy, SWOT and Corporate Finance Report
Summary
Valensa International LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Valensa International LLC (Valensa) is a biotechnology company. The company primarily produces nutraceutical and functional ingredients for the pharmaceutical, cosmeceutical, dietary supplement and functional food industry. Valensa’s product portfolio includes carotenoids, spirulina, plant and Omega-3 fatty acid, saw palmetto extract, and other health products, among others. It offers ingredients such as Zanthin natural astaxanthin, parry organic spirulina, Usplus saw palmetto, euglena gracilis, and parry organic chlorella, mainly used in the development of products. The company markets its products under , USPlus, Cran-Gyn, Flex Pro ES, Flex Pro MD, Eye Pro MD, Prostate 360 and SpiruZan brands. Valensa is headquartered in Eustis, Florida, the US
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook